Literature DB >> 28612001

Botulinum Toxin Off-Label Use in Dermatology: A Review.

Anna Campanati1, Emanuela Martina1, Katia Giuliodori1, Veronica Consales1, Ivan Bobyr1, Annamaria Offidani1.   

Abstract

BACKGROUND: Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum which causes a flaccid muscle paralysis. It is currently used for aesthetic treatments and in the focal hyperhidrosis. Recently, botulinum toxin has also been used experimentally in many other dermatological conditions with good results.
OBJECTIVE: To review and analyze the possible botulinum toxin off-label applications published.
METHODS: A retrospective review of the published data was conducted.
CONCLUSIONS: this potent drug can lead to several off-label indications of interest for dermatologists. Further clinical trials are still needed to better understand the real efficacy and safety of these applications and to standardize injection and dose protocols.

Entities:  

Keywords:  Botulinum toxin; Folds dermatitis; Hidradenitis suppurativa; Keloids; Off-label therapy

Year:  2017        PMID: 28612001      PMCID: PMC5465664          DOI: 10.1159/000452341

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  121 in total

1.  Aquagenic palmoplantar keratoderma.

Authors:  A C Yan; S Z Aasi; W J Alms; W D James; W R Heymann; A S Paller; P J Honig
Journal:  J Am Acad Dermatol       Date:  2001-04       Impact factor: 11.527

2.  Notalgia paresthetica: clinical, physiopathological and therapeutic aspects. A study of 12 cases.

Authors:  N Raison-Peyron; L Meunier; M Acevedo; J Meynadier
Journal:  J Eur Acad Dermatol Venereol       Date:  1999-05       Impact factor: 6.166

3.  Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates.

Authors:  H G Gassner; D A Sherris; C C Otley
Journal:  Plast Reconstr Surg       Date:  2000-05       Impact factor: 4.730

4.  Pachyonychia congenita: mutations and clinical presentations.

Authors:  C S Munro
Journal:  Br J Dermatol       Date:  2001-05       Impact factor: 9.302

5.  Epidermolysis bullosa simplex.

Authors:  Jason F Okulicz; Nadia I Kihiczak; Camila K Janniger
Journal:  Cutis       Date:  2002-07

6.  Botulinum toxin type A as an effective adjuvant therapy for Hailey-Hailey disease.

Authors:  Nam-Gyu Kang; Tae-Jin Yoon; Tae-Heung Kim
Journal:  Dermatol Surg       Date:  2002-06       Impact factor: 3.398

7.  Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses?

Authors:  Dirk Dressler; Alexander Münchau; Kailash P Bhatia; Niall P Quinn; Hans Bigalke
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

8.  Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison.

Authors:  U Wollina; T Karamfilov
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-01       Impact factor: 6.166

9.  Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease.

Authors:  J C Lapiere; A Hirsh; K B Gordon; B Cook; A Montalvo
Journal:  Dermatol Surg       Date:  2000-04       Impact factor: 3.398

10.  Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin.

Authors:  Carl Swartling; Hans Naver; Magnus Lindberg; Ingegard Anveden
Journal:  J Am Acad Dermatol       Date:  2002-11       Impact factor: 11.527

View more
  15 in total

1.  Evaluation of Botulinum Toxin Type A Injection in the Treatment of Localized Chronic Pruritus.

Authors:  Khaled Gharib; Asmaa Mostafa; Ayman Elsayed
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.

Authors:  Enayat Mohamed Atwa; Mohamed Mahmoud Nasr; Howyda M Ebrahim
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

3.  Successful Topical Application of Botulinum Toxin After Microneedling Versus Microneedling Alone for the Treatment of Atrophic Post Acne Scars: A Prospective, Split-face, Controlled Study.

Authors:  Howyda Ebrahim; Amal Elardi; Sayed Khater; Hala Morsi
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

4.  Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature.

Authors:  Anna Campanati; Emanuela Martina; Stamatis Gregoriou; George Kontochristopoulos; Matteo Paolinelli; Federico Diotallevi; Giulia Radi; Ivan Bobyr; Barbara Marconi; Giulio Gualdi; Paolo Amerio; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2022-05-27       Impact factor: 5.075

Review 5.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

6.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05

Review 7.  Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.

Authors:  Katharine E Alter; Barbara I Karp
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

Review 8.  Antipruritic Effects of Botulinum Neurotoxins.

Authors:  Parisa Gazerani
Journal:  Toxins (Basel)       Date:  2018-03-29       Impact factor: 4.546

9.  New trends in botulinum toxin use in dermatology.

Authors:  Stefania Guida; Francesca Farnetani; Steven P Nisticò; Caterina Giorgio Mariarosaria; Graziella Babino; Giovanni Pellacani; Elisabetta Fulgione
Journal:  Dermatol Pract Concept       Date:  2018-10-31

Review 10.  Dynamic Relaxers of the Face.

Authors:  Rashmi Shetty
Journal:  J Cutan Aesthet Surg       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.